A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
Phase 1 Completed
23 enrolled
RAPIRI
Phase 1 Completed
42 enrolled
Haplo Peripheral Blood Sct In GVHD Prevention
Phase 1 Completed
25 enrolled
METZOLIMOS
Phase 1 Completed
23 enrolled 15 charts
Vorinostat and Temsirolimus With or Without Radiation Therapy in Treating Younger Patients With Newly Diagnosed or Progressive Diffuse Intrinsic Pontine Glioma
Phase 1 Completed
18 enrolled
Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT
Phase 1 Completed
32 enrolled 12 charts
A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer
Phase 1 Completed
22 enrolled
Sirolimus or Vorinostat and Hydroxychloroquine in Advanced Cancer
Phase 1 Completed
143 enrolled
Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention
Phase 1 Completed
5 enrolled
Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma
Phase 1 Completed
19 enrolled
Aflac ST0901
Phase 1 Completed
18 enrolled
Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Phase 1 Completed
7 enrolled
Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS Tumours
Phase 1 Completed
14 enrolled
UPCC 02407
Phase 1 Completed
16 enrolled
Sirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery
Phase 1 Completed
56 enrolled
A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors
Phase 1 Completed
24 enrolled
Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery
Phase 1 Completed
31 enrolled
T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer
Phase 1 Completed
41 enrolled
Hydroxychloroquine, Cyclophosphamide, Dexamethasone, and Sirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase 1 Completed
18 enrolled
Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid Tumors
Phase 1 Completed
21 enrolled
Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant
Phase 1 Completed
46 enrolled 11 charts
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 1 Completed
146 enrolled 42 charts
Rapamycin in Relapsed Acute Lymphoblastic Leukemia
Phase 1 Completed
6 enrolled
Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants
Phase 1 Completed
16 enrolled
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
Phase 1 Completed
19 enrolled
SU/Rapamycin
Phase 1 Completed
19 enrolled
Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCC
Phase 1 Completed
300 enrolled
Sirolimus and Cetuximab in Advanced Malignancies
Phase 1 Completed
165 enrolled
Lapatinib With Sirolimus or Metformin
Phase 1 Completed
111 enrolled
Temsirolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Phase 1 Completed
3 enrolled
Cixutumumab and Temsirolimus in Treating Patients With Locally Advanced or Metastatic Cancer
Phase 1 Completed
72 enrolled
Tivantinib and Temsirolimus in Treating Patients With Solid Tumors That is Metastatic or Cannot be Removed by Surgery
Phase 1 Completed
11 enrolled
Docetaxel and Sirolimus in Patients With Advanced Malignancies
Phase 1 Completed
103 enrolled
Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Phase 1 Completed
21 enrolled
Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Phase 1 Completed
13 enrolled
Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma
Phase 1 Completed
33 enrolled
Sorafenib and Temsirolimus in Treating Patients With Unresectable or Metastatic Solid Tumors
Phase 1 Completed
40 enrolled
Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma
Phase 1 Completed
7 enrolled
Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
38 enrolled
Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
18 enrolled
Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment
Phase 1 Completed
39 enrolled
Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma
Phase 1 Completed
69 enrolled
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Phase 1 Completed
72 enrolled
Rapamycin With Grapefruit Juice for Advanced Malignancies
Phase 1 Completed
41 enrolled
Rapamycin Plus Bevacizumab in Advanced Cancers
Phase 1 Completed
28 enrolled
Rapamycin in Advanced Cancers
Phase 1 Completed
40 enrolled
Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.
Phase 1 Completed
12 enrolled
Lenalidomide and Temsirolimus in Treating Patients With Previously Treated Multiple Myeloma
Phase 1 Completed
25 enrolled
Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Phase 1 Completed
27 enrolled
Drug Interaction Study of Sorafenib and Rapamycin in Advanced Malignancies
Phase 1 Completed
34 enrolled